"Altea Research Institute is a Clinical Research Site that primarily focuses on psychiatric and women's health research studies."

During the past decade, Altea Research Institute conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 29 clinical trials were completed, i.e. on average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 22 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altea Research Institute" #1 sponsor was "Indivior Inc." with 6 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 6 trials sponsored, "Karuna Therapeutics" with 4 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored and "Allergan" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altea Research Institute" #1 collaborator was "Neumora Therapeutics, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Veristat, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Altea Research Institute" are "Schizophrenia" (13 trials), "Depressive Disorder, Major" (8 trials), "Major Depressive Disorder" (3 trials), "Opioid-related Disorders" (3 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Altea Research Institute" in a lesser frequency.

Most popular intervention types in "Altea Research Institute" are "Drug" (45 trials), "Other" (3 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Rapastinel" (6 trials), "Xanomeline and Trospium Chloride Capsules" (4 trials), "RBP-6000" (3 trials) and "Atogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Altea Research Institute" are 47 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Altea Research Institute". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Altea Research Institute, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Altea Research Institute, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".